View Older Stories

Jun 16, 2026 06:42AM Amgen (AMGN) PT Raised to $303 at Mizuho

Jun 12, 2026 08:25AM Piper Sandler Reiterates Overweight Rating on Amgen (AMGN)

Jun 9, 2026 04:38PM Amgen (AMGN) PT Raised to $340 at Morgan Stanley

Jun 8, 2026 02:56AM AMGEN's Repatha shows 29% cardiovascular event reduction in diabetes study

May 15, 2026 03:50PM Kissei Pharmaceutical warns against new TAVNEOS prescriptions amid safety concerns

May 14, 2026 08:25AM Amgen (AMGN) PT Lowered to $427 at Piper Sandler

May 7, 2026 08:30AM Freedom Broker Upgrades Amgen (AMGN) to Buy

May 5, 2026 06:16AM Erste Group Downgrades Amgen (AMGN) to Hold

May 4, 2026 09:01AM AMGEN announces $300 million US manufacturing investment

May 4, 2026 07:24AM Amgen (AMGN) PT Lowered to $340 at Guggenheim

May 1, 2026 05:59AM Amgen (AMGN) PT Raised to $307 at BofA Securities

Apr 30, 2026 04:03PM Amgen (AMGN) Tops Q1 EPS by 35c, Offers Guidance

Apr 30, 2026 03:30AM Amgen (AMGN) call put ratio 1.5 calls to 1 put with a focus on May 365 calls into quarter results

Apr 29, 2026 11:23AM Amgen (AMGN) call put ratio 1.6 calls to 1 put into quarter results

Apr 28, 2026 01:46PM AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring

Apr 20, 2026 04:12PM Canaccord Starts Amgen (AMGN) at Hold

Apr 13, 2026 09:34AM Amgen (AMGN) PT Raised to $400 at UBS

Apr 9, 2026 07:10AM Amgen (AMGN) PT Raised to $351 at Guggenheim

Apr 8, 2026 09:15AM Amgen (AMGN) PT Raised to $325 at Truist Securities

Apr 8, 2026 07:41AM Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald Amid Negative/Neutral Sentiment

Apr 6, 2026 12:41PM William Blair on Amgen (AMGN): top-line results show 'strong efficacy' compared to VRDN data

Apr 6, 2026 09:46AM Stifel on Viridian (VRDN): 'We view positive REVEAL-2 chronic TED data in 2Q26 as important'

Apr 2, 2026 08:07AM RBC Capital: 'Amgen (AMGN) Highlights Key Growth Drivers For The Rest Of 2026 And Beyond'

Mar 31, 2026 03:14PM Amgen’s Tavneos Tied to Deaths, Liver Injury - FDA

Mar 30, 2026 04:38PM Jefferies on Amgen (AMGN): Elegrobart data not a 'significant competitive threat to Tepezza'

Mar 10, 2026 05:38AM Jefferies Starts Amgen (AMGN) at Hold

Mar 10, 2026 05:38AM Jefferies Starts Vertex (VRTX) at Buy

Mar 10, 2026 05:38AM Jefferies Starts Gilead Sciences (GILD) at Buy

Mar 9, 2026 10:53AM FDA: 'The agency today is withdrawing final guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product'

Mar 5, 2026 04:16PM Leerink Partners Reiterates Market Perform Rating on Amgen (AMGN), lowers estimates

Mar 4, 2026 04:02PM Amgen (AMGN) Declares $2.52 Quarterly Dividend; 2.7% Yield

Feb 20, 2026 07:54AM Barclays Starts Amgen (AMGN) at Equalweight

Feb 19, 2026 08:58AM TD Cowen on Amgen's (AMGN) Dazodalibep: 'An Overlooked Gem In Amgen's Pipeline?'

Feb 18, 2026 07:21AM Amgen (AMGN) PT Raised to $432 at Piper Sandler

Feb 13, 2026 04:50PM Amgen (AMGN) files mixed shelf

Feb 12, 2026 03:54PM Freedom Capital Markets Downgrades Amgen (AMGN) to Hold (mid morning)

Feb 6, 2026 07:29AM Amgen (AMGN) PT Raised to $347 at Guggenheim

Feb 4, 2026 12:27PM BofA on Amgen (AMGN): 'Catalysts: pelacarsen readthrough shifts to mid-2026'

Feb 4, 2026 09:59AM Amgen (AMGN) PT Raised to $350 at Cantor Fitzgerald

Feb 4, 2026 08:10AM Amgen (AMGN) PT Raised to $360 at RBC Capital

Feb 4, 2026 05:37AM Amgen (AMGN) PT Raised to $420 at TD Cowen

Feb 3, 2026 04:30PM After-hours movers: AMD, Chipotle, Lumentum, Silicon Labs and more

Feb 3, 2026 04:02PM Amgen (AMGN) Tops Q4 EPS by 56c, Beats on Revenue; Offers FY26 Guidance

Feb 3, 2026 10:32AM Amgen (AMGN) call put ratio 1 call to 1 put into quarter results

Feb 3, 2026 05:37AM Amgen (AMGN) call put ratio 1.1 calls to 1 put into quarter results

Feb 2, 2026 10:30AM Amgen (AMGN) call put ratio 2.3 calls to 1 put into quarter results

Feb 2, 2026 05:09AM Amgen (AMGN) call put ratio 1 call to 1.4 puts into quarter results

Jan 30, 2026 11:17AM Amgen (AMGN) call put ratio 1 call to 1.6 puts into quarter results

Jan 21, 2026 10:00AM This U.S. biotech stock is Bernstein's Top Pick for 2026

Jan 20, 2026 09:21AM Bernstein SocGen Group Downgrades Amgen (AMGN) to Market Perform

View Older Stories